Impact Biomedical (IBO) Tax Rate (2022)
Impact Biomedical's (IBO) quarterly Tax Rate came in at 35.82% in Q4 2022, up 127.85% quarter-over-quarter from 128.63% in Q3 2022.
Powered by 
Analysis
Impact Biomedical (IBO) Tax Rate (2022) Analysis & Trends
Impact Biomedical (IBO) has reported Tax Rate for 1 consecutive years, with 35.82% the latest figure, recorded in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 15.11% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -10.89% |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 26.36% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 1.34% |
| 10 | Impact Biomedical | 49.63 Mn | 49.62 Mn | 2,000.00 | - |